 only from
purely retrospective data. As such, for patients with a
poor life expectancy and an asymptomatic PAA, it
may be reasonable to defer any intervention. If treatment of a PAA is indicated for such patients, because
endovascular treatment is less taxing and has fewer
postoperative complications, EPAR should be considered, regardless of the availability of the GSV or quality
of the runoff vessels.
Our literature review suggests that younger age, the
availability of